oxazoles has been researched along with Pleurisy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Abed, Y; Claesson, M; Cuzzocrea, S; Donia, M; Kim, J; Mangano, K; Mazzon, E; Miljkovic, D; Nicoletti, F; Stojanovic, I; Stosic-Grujicic, S; Wang, M | 1 |
1 other study(ies) available for oxazoles and Pleurisy
| Article | Year |
|---|---|
In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models.
Topics: Acetates; Acetylmuramyl-Alanyl-Isoglutamine; Animals; Arthritis, Experimental; CD4-Positive T-Lymphocytes; Cell Proliferation; Cell Survival; Cytokines; Female; I-kappa B Proteins; Immunologic Factors; Leukocytes, Mononuclear; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Mitogen-Activated Protein Kinases; Oxazoles; Phosphorylation; Pleurisy; Shock, Septic; Spleen; Survival Rate | 2007 |